Table 2. Characteristics of patients stratified according to BCVA.
| Variables | Group A (n = 41) |
Group B (n = 34) |
P value |
|---|---|---|---|
| Age, (mean ± SD, years) | 56.51 ± 12.01 | 58.15 ± 11.97 | 0.558 |
| Gender, male (n, %) | 13, 31.71% | 15, 44.12% | 0.269 |
| Type of RVO, BRVO (n, %) | 31, 75.61% | 25, 73.53% | 0.837 |
| Time from onset to treatment, (median) | 30 | 30 | 0.970 |
| Injections frequency (mean ± SD) | 2.63 ± 1.48 | 1.24 ± 0.65 | <0.01 |
| Co-morbidities (n) | |||
| Hypertension | 10 | 23 | <0.01 |
| Hyperlipemia | 12 | 21 | 0.005 |
| Smoking (n) | 17 | 24 | 0.012 |
Notes.
- BCVA
- best-corrected visual acuity
- RVO
- Retinal vein occlusion
- BRVO
- Branch retinal vein occlusion